InsiderTrades.com logo
Michael R. Davin net worth and biography
  • Phone
  • Email
  • Website

Michael Davin Biography and Net Worth

Director of Allurion Technologies

Michael Davin has served as a member of the Allurion Board since October 2017.
Mr. Davin has also served as a director of Follica, Inc. since December 2020, as a director of Amsel Medical Corporation since August 2020, as a director of Cynosure, LLC since January 2020, and as a director of Inkbit Corporation since June 2018. Previously, Mr. Davin served as chairman, president and chief executive officer of Cynosure Inc., a publicly traded company, from 2003 until March 2017, when it was acquired by Hologic Inc. Mr. Davin received his B.S. and B.A. from Southern New Hampshire University. Mr. Davin was nominated to serve on the Allurion board due to his experience as a director of health care and technology companies, as well as his familiarity with Allurion as a director.

What is Michael R. Davin's net worth?

The estimated net worth of Michael R. Davin is at least $62.06 as of December 3rd, 2025. Mr. Davin owns 107 shares of Allurion Technologies stock worth more than $62 as of October 7th. This net worth approximation does not reflect any other assets that Mr. Davin may own. Learn More about Michael R. Davin's net worth.

How do I contact Michael R. Davin?

The corporate mailing address for Mr. Davin and other Allurion Technologies executives is 11 Huron Drive, Natick, MA 01760, United States. Allurion Technologies can also be reached via phone at 508-647-4000 and via email at [email protected]. Learn More on Michael R. Davin's contact information.

Has Michael R. Davin been buying or selling shares of Allurion Technologies?

Michael R. Davin has not been actively trading shares of Allurion Technologies over the course of the past ninety days. Most recently, Michael R. Davin sold 107 shares of the business's stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $22.20, for a transaction totalling $2,375.40. Following the completion of the sale, the director now directly owns 107 shares of the company's stock, valued at $2,375.40. Learn More on Michael R. Davin's trading history.

Who are Allurion Technologies' active insiders?

Allurion Technologies' insider roster includes Michael Davin (Director), and Shantanu Gaur (CEO). Learn More on Allurion Technologies' active insiders.

Are insiders buying or selling shares of Allurion Technologies?

In the last year, insiders at the sold shares 1 times. They sold a total of 107 shares worth more than $2,375.40. The most recent insider tranaction occured on December, 3rd when Director Michael R. Davin sold 107 shares worth more than $2,375.40. Insiders at Allurion Technologies own 8.1% of the company. Learn More about insider trades at Allurion Technologies.

Information on this page was last updated on 12/3/2025.

Michael R. Davin Insider Trading History at Allurion Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/3/2025Sell107$22.20$2,375.40107View SEC Filing Icon  
See Full Table

Michael R. Davin Buying and Selling Activity at Allurion Technologies

This chart shows Michael R. Davin's buying and selling at Allurion Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Allurion Technologies Company Overview

Allurion Technologies logo
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Read More

Today's Range

Now: $0.58
Low: $0.55
High: $0.60

50 Day Range

MA: $6.74
Low: $0.58
High: $15.15

2 Week Range

Now: $0.58
Low: $0.23
High: $3.33

Volume

25,789 shs

Average Volume

1,452,776 shs

Market Capitalization

$8.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A